Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$31.3K Buy
370
+2
+0.5% +$161 0.01% 261
2026
Q1
$26.1K Buy
368
+1
+0.3% +$75 0.01% 253
2025
Q4
$28.9K Buy
367
+2
+0.5% +$158 0.01% 237
2025
Q3
$30.1K Buy
365
+2
+0.6% +$157 0.01% 228
2025
Q2
$29.2K Buy
363
+1
+0.3% +$77 0.01% 202
2025
Q1
$29K Buy
362
+2
+0.6% +$166 0.02% 188
2024
Q4
$29.5K Buy
360
+1
+0.3% +$83 0.02% 187
2024
Q3
$29.6K Buy
359
+2
+0.6% +$149 0.02% 180
2024
Q2
$25.1K Buy
357
+2
+0.6% +$143 0.02% 174
2024
Q1
$26.3K Buy
355
+1
+0.3% +$70 0.02% 173
2023
Q4
$23.4K Buy
354
+2
+0.6% +$125 0.02% 179
2023
Q3
$22.2K Buy
352
+2
+0.6% +$125 0.02% 169
2023
Q2
$19.8K Buy
350
+2
+0.6% +$111 0.02% 192
2023
Q1
$20.2K Buy
348
+1
+0.3% +$67 0.02% 162
2022
Q4
$25.1K Buy
347
+2
+0.6% +$143 0.03% 136
2022
Q3
$21K Buy
345
+1
+0.3% +$64 0.02% 142
2022
Q2
$21.6K Buy
344
+2
+0.6% +$132 0.02% 144
2022
Q1
$24K Buy
342
+1
+0.3% +$68 0.02% 146
2021
Q4
$21.3K Buy
+341
New +$21.4K 0.02% 156

Other funds holding MET

PFS Partners's MET Position: Q2 2026 in Review

PFS Partners increased its MetLife (MET) stake by 0.54% in Q2 2026, buying an estimated $161 and bringing the position to 370 shares worth $31.3K. The position accounts for 0.01% of the portfolio, ranked #261.

PFS Partners first reported a position in MET in Q4 2021 and has held it in 19 quarters since. 423 funds tracked by Wall St. Rank hold MET as of Q2 2026.

  • PFS Partners held 370 shares of MetLife worth $31.3K as of Q2 2026.
  • PFS Partners bought 2 MetLife shares in Q2 2026, an estimated $161.
  • MetLife made up 0.01% of PFS Partners's portfolio in Q2 2026, its #261 holding.
  • PFS Partners first reported a position in MetLife in Q4 2021 and has held it in 19 quarters since.
  • 423 funds tracked by Wall St. Rank held MetLife as of Q2 2026.

Based on PFS Partners's 13F filing for Q2 2026, filed 20 Jul 2026.